Search

everythinglearnresearchcommunity

for

Search:↓

Injections improve hair growth, density, and thickness in women safely.

Niacin derivatives may increase hair fullness in women with hair loss.

The document concludes that proper diagnosis and individualized treatment are crucial for managing androgenization in women effectively.

Treatment with plasma rich in growth factors improved hair density and thickness for hair loss patients.

The report concludes that PCOS is mainly a condition of excess male hormones and its definition may change as new information is discovered.

Peripilar signs can help diagnose androgenetic alopecia and reveal its cause.

Topical drugs and near-infrared light therapy show potential for treating alopecia.

Allergic reactions to blood thinners are rare but can be serious, requiring careful management and alternative treatments.

Women with androgenetic alopecia experience worse physical well-being and quality of life, but similar mental health compared to those without it.

The article concludes that correctly diagnosing systemic causes of hair loss requires a detailed clinical evaluation and a systematic diagnostic approach.

The document concludes that proper diagnosis and evidence-based treatments are crucial for managing hair diseases, and psychological support for patients is important.

Asian patients with Frontal Fibrosing Alopecia often lose eyebrow hair and respond well to combined antiandrogen or antimalarial and topical treatments.

Minoxidil base is preferred for hair loss treatment, but minoxidil sulfate may be an alternative for unresponsive patients.

The conference highlighted new dermatological treatments and emphasized early intervention and addressing conditions lacking evidence-based treatments.

Follicular Unit Transplantation is a precise hair restoration technique that requires careful planning and a skilled team, and Follicular Unit Extraction offers a less invasive option.

The document concludes that alopecia has significant social and psychological effects, leading to a market for hair loss treatments.

Different hair diseases affect people during childbearing years, with treatments ranging from medication to psychological support.

Some plant-based chemicals may help with hair growth, but more research is needed to confirm their effectiveness.

The guideline suggests using specific criteria to diagnose PCOS, recommends various treatments for its symptoms, and advises screening for related health issues.

The secretions of mesenchymal stem cells could be used for healing without using the cells themselves.

Methotrexate treats various disorders by inhibiting DNA synthesis, but careful monitoring is needed to avoid toxicity and manage side effects.

Allergic reactions to blood thinners are rare but can be serious, requiring careful testing and alternative treatments.

Chronic Telogen Effluvium may resolve after years and is diagnosed by examining the patient's history and clinical signs, with treatment aimed at underlying causes and possibly minoxidil.

Sex hormones may affect COVID-19 severity, with men often faring worse, and targeting related pathways could offer treatment options.

Menopause affects hair and skin; more research needed for treatment.

PCOS is a complex disorder managed by treating symptoms and requires a team of specialists.

CRTH2 antagonists might be useful for treating many conditions because they play a role in immune and inflammation responses.

Hormonal therapies help treat female hair loss, but results are slow and vary.

Platelet-Rich Plasma (PRP), a protein-rich extract from a patient's blood, shows promise in improving hair density, thickness, and quality, but the best method of use and number of treatments needed for noticeable results are still unclear.

The new compound was more effective than finasteride in reducing markers of hair loss and prostate issues in cell tests.